Clarivate Plc filings document the financial reporting, governance and capital structure of a Jersey-incorporated public company that provides enriched data, analytics, workflow solutions and expert services across Academia & Government, Intellectual Property, and Life Sciences & Healthcare. Current reports furnish quarterly and annual earnings releases, supplemental revenue, earnings and guidance materials, and Regulation FD presentations.
The company's SEC records also cover proxy governance and executive compensation matters, including annual meeting disclosures and executive severance plan terms. Other filings describe financing arrangements involving subsidiaries, credit agreement amendments, senior secured note redemption and satisfaction and discharge, and related material-event disclosures under the Exchange Act.
CLARIVATE PLC director Wendell E. Pritchett received an annual non-employee director award of 62,264 restricted share units, reflected as ordinary shares, under the Clarivate Plc Amended and Restated 2019 Incentive Award Plan. Earlier, 3,367 shares were withheld at $2.44 per share to cover taxes. Following these transactions, he directly holds 160,708 ordinary shares.
Clarivate Plc director Jane L. Okun Bomba reported routine equity compensation and related tax withholding. She received an annual non-employee director award of 62,264 restricted share units, granted at no cash cost under the Clarivate Plc Amended and Restated 2019 Incentive Award Plan. In a separate entry, 2,851 ordinary shares were withheld at $2.44 per share to cover tax obligations, which is not an open‑market sale. After these transactions, she directly holds 299,677 ordinary shares and indirectly holds 49,750 ordinary shares through the Jane Okun Bomba Trust dated December 20, 2018.
Clarivate plc director Saurabh Saha reported routine equity compensation and related tax withholding. On an award date, he acquired 62,264 ordinary shares at no cost as an annual non-employee director grant of restricted share units under the Clarivate Plc Amended and Restated 2019 Incentive Award Plan, bringing his direct holdings to 170,601 shares. A separate transaction shows 8,178 shares were withheld at $2.44 per share to cover tax obligations, a non-market disposition that reduced his direct holdings to 108,337 shares at that time.
Clarivate plc director Kenneth L. Cornick reported equity compensation and related tax withholding transactions. On May 14, he received an annual non-employee director award of 62,264 restricted share units representing Ordinary Shares under the Clarivate Plc Amended and Restated 2019 Incentive Award Plan, increasing his direct holdings to 102,038 Ordinary Shares.
On May 13, 5,990 Ordinary Shares were withheld at $2.44 per share to cover tax obligations, leaving 39,774 Ordinary Shares directly held after that transaction. Separately, Cornick Family Investor, LLC, which is controlled by Mr. Cornick and his spouse, holds 1,100,000 Ordinary Shares as an indirect position.
Clarivate PLC director Andrew Miles Snyder reported routine equity compensation and related tax withholding. He received an annual non-employee director award of 62,264 restricted share units of ordinary shares at no cost under the Clarivate Plc Amended and Restated 2019 Incentive Award Plan. In connection with equity compensation, 2,841 shares were withheld at $2.44 per share to cover tax obligations. Following these transactions, Snyder directly holds 270,703 ordinary shares. He also has indirect holdings through Cambridge Information Group entities and the Snyder 2011 Family Trust, for which he disclaims beneficial ownership beyond his pecuniary interest.
Clarivate Plc director Suzanne Heywood reported routine equity compensation and related tax withholding. On May 14, she received an annual non-employee director award of 62,264 Ordinary Shares in the form of restricted share units under the Clarivate Plc Amended and Restated 2019 Incentive Award Plan, at a stated price of $0.00 per share. On May 13, 19,690 Ordinary Shares were withheld at $2.44 per share to cover tax obligations. Following these transactions, she directly holds 93,979 Ordinary Shares.
Clarivate PLC reports a joint Schedule 13G/A disclosing 42,846,530 Ordinary Shares, representing 6.70% of the class. The filing states this percentage is based on 639,216,510 Ordinary Shares outstanding as of March 31, 2026 per the issuer's Form 10-Q. The disclosure names Clarkston Capital Partners, LLC, Clarkston Companies, Inc., Clarkston Third Financial, LLC, Jeffrey A. Hakala and Gerald W. Hakala as joint filers and itemizes voting and dispositive powers for the holdings.
Clarivate PLC executive Henry Levy, President, LS&H, had 19,893 Ordinary Shares withheld on May 1, 2026 to cover taxes due when his restricted share units vested. This was a tax-withholding disposition at $2.79 per share, not an open-market sale. After the withholding, he directly holds 983,373 Ordinary Shares, so his overall stake in Clarivate remains substantial.
Clarivate Plc reported a Q1 2026 net loss of $40.2 million on revenue of $585.5 million, down 1.4% year over year. Operating income improved to $30.2 million from a $20.8 million loss as cost of revenues fell 7% and restructuring charges roughly halved.
Adjusted EBITDA rose to $241.2 million with a 41.2% margin, up from 39.3%. Net cash from operating activities was $134.7 million and free cash flow was $78.9 million. The company ended the quarter with $242.2 million in cash and $4.3 billion of debt, and repurchased 7 million shares for $18.1 million. Clarivate is pursuing a potential sale of its Life Sciences & Healthcare segment to sharpen focus on its Academia & Government and Intellectual Property businesses.
Clarivate Plc reported a mixed but improving first quarter of 2026. Revenue was $585.5 million, down 1.4% from a year earlier, mainly due to business disposals, while organic revenue grew modestly. Subscription sales rose, helping recurring revenue grow 1.0% organically.
Profitability and cash generation strengthened in quality. Net loss narrowed to $40.2 million from $103.9 million, and Adjusted EBITDA increased to $241.2 million with margin improving to 41.2%. Adjusted diluted EPS rose to $0.18. Free cash flow was $78.9 million, below last year, partly because of higher working-capital outflows.
The company continued to deleverage and reaffirmed its 2026 outlook. Clarivate used strong operating cash flow to retire $143 million of debt and repurchased $18 million of shares. For full-year 2026, it reaffirmed guidance for revenue of $2.30–$2.42 billion, Adjusted EBITDA of $980 million–$1.04 billion, Adjusted diluted EPS of $0.70–$0.80 and free cash flow of $365–$435 million.